http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1669082-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_850a17186ff51f03c607cf42a534a635
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36
filingDate 2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e46aea3989a13e97e52a2ea763621469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c70bd7a8a7cd16e4af5e101cd459ba93
publicationDate 2006-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1669082-A1
titleOfInvention Dried extract from inflammatory rabbit skin inoculated with vaccinia virus and process for its manufacture
abstract An object of the present invention is to provide a dried product of an extract from inflammatory rabbit skin inoculated with vaccinia virus having an inhibitory activity for the production of a kallikrein-like substance and also to provide a process for manufacturing the same. n The present invention relates to a process for the manufacture of a dried product of the present extract, characterized in that, in the drying for the manufacture of a solid preparation containing an extract from inflammatory rabbit skin inoculated with vaccinia virus as an effective ingredient, a saccharide, sugar alcohol or ascorbic acid is added thereto and mixed therewith before getting to dryness and then the mixture is dried. In accordance with the present manufacturing process, it is now possible to prepare a dried product having an inhibitory activity for the production of a kallikrein-like substance of the present extract and it is also possible to manufacture a solid preparation for oral administration such as tablets using the above.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010054531-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109512838-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109512838-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265345-B2
priorityDate 2004-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004060381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1557171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0341209-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0348353-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129511767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129511773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57321363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136320588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129084604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128650051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226500596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129332267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453

Total number of triples: 75.